Loading stock data...
Last Updated: 10 Mar 2026, 03:58:19 PM (IST)

Samsrita Labs Ltd.

BSE: SAMSRITA

BSE
18.94 1.10 (6.17%)

Prev Close

17.84

Open Price

17.8

Volume

1,902

Today Low / High

17.8 / 18.95

52 WK Low / High

12.19 / 26.04

Range

18 - 20

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 18.94, reflecting a change of 1.1 (6.16592%). The expected target range on the BSE is 18 - 20. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

Samsrita Labs Ltd. Graph

Samsrita Labs Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Samsrita Labs Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 18.94, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 18.94 19.13 17.22 - 21.04
19.32 15.46 - 23.18
19.51 13.66 - 25.36
Bearish Scenario 18.94 18.75 16.88 - 20.63
18.56 14.85 - 22.27
18.37 12.86 - 23.88

Overview of Samsrita Labs Ltd.

ISIN

INE579N01018

Industry

Biotechnology

Vol.Avg

1,429

Market Cap

261,669,729

Last Dividend

0

Official Website

Visit Website

IPO Date

2015-08-11

DCF Diff

19.35

DCF

-2

Financial Ratios Every Investor Needs

Stock Rating Details for SAMSRITA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.16 Cr -0.13 Cr -0.26 Cr -0.18 -0.26 Cr 0.0000
2024-03-31 0.00 Cr 0.13 Cr -0.13 Cr 0.0000 0.00 Cr 0.02 Cr -0.25 Cr -0.26 Cr -0.18 -0.25 Cr 0.0000
2023-03-31 0.02 Cr 0.02 Cr 0.00 Cr 0.0556 0.00 Cr 0.11 Cr -0.25 Cr -0.71 Cr -0.48 -0.70 Cr -32.7407
2022-03-31 0.02 Cr 0.15 Cr -0.13 Cr -5.7985 0.00 Cr 0.02 Cr -0.40 Cr 1.49 Cr 1.00 1.51 Cr 66.2376
2021-03-31 0.01 Cr 0.01 Cr 0.01 Cr 0.5909 0.00 Cr 0.04 Cr -0.91 Cr -0.77 Cr -0.52 -0.91 Cr -59.3337

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.00 Cr 15.68 Cr 3.60 Cr 12.0837 Cr 2.43 Cr 2.42 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 4.87 Cr 3.4833 Cr
2024-03-31 0.00 Cr 15.55 Cr 3.29 Cr 12.2578 Cr 2.20 Cr 2.20 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 4.79 Cr 3.1929 Cr
2023-03-31 0.01 Cr 15.56 Cr 3.04 Cr 12.5201 Cr 2.08 Cr 2.07 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 4.80 Cr 2.9571 Cr
2022-03-31 0.01 Cr 17.13 Cr 3.90 Cr 13.2272 Cr 2.74 Cr 2.73 Cr -0.04 Cr 0.01 Cr 0.00 Cr 0.00 Cr 4.80 Cr 3.8306 Cr
2021-03-31 0.00 Cr 16.58 Cr 5.42 Cr 11.1519 Cr 2.34 Cr 2.34 Cr 0.13 Cr 0.02 Cr 0.00 Cr 0.00 Cr 4.22 Cr 5.3793 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.2253 Cr 0.0000 Cr 0.2234 Cr -0.2253 Cr -0.0019 Cr 0.0024 Cr 0.0000 Cr -0.2595 Cr 0.2236 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.1286 Cr 0.0000 Cr 0.1277 Cr -0.1286 Cr -0.0009 Cr 0.0043 Cr 0.1286 Cr -0.2622 Cr 0.1277 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 0.6612 Cr 0.0000 Cr -0.6652 Cr 0.6612 Cr -0.0040 Cr 0.0053 Cr 0.0000 Cr -0.7057 Cr 0.6652 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -0.3950 Cr 0.0000 Cr 0.4002 Cr -0.3950 Cr 0.0051 Cr 0.0092 Cr 0.0000 Cr 1.4873 Cr 0.4002 Cr 0.0000 Cr 0.1292 Cr
2021-03-31 -0.3411 Cr -0.2273 Cr 0.5490 Cr -0.5684 Cr -0.0253 Cr 0.0041 Cr -0.2273 Cr -0.7697 Cr 0.5490 Cr 0.0000 Cr 0.0019 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -3.36 Cr -2.94 Cr -1.29 -3.36 Cr 0.0000
2025-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -4.94 Cr -4.55 Cr -2.00 -4.93 Cr 0.0000
2025-06-30 0.00 Cr 0.16 Cr -0.16 Cr 0.0000 -0.16 Cr -0.28 Cr -0.19 -0.28 Cr 0.0000
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.05 Cr -0.09 Cr -0.06 0.00 Cr 0.0000
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.03 Cr -0.04 Cr -0.03 -0.04 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 1.93 Cr 0.00 Cr 1.93 Cr 0.00 Cr 0.00 Cr 2.82 Cr 0.00 Cr 18.11 Cr 2.69 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -12.08 Cr
2025-03-31 0.00 Cr 0.00 Cr 0.00 Cr 2.09 Cr 0.00 Cr 5.54 Cr 0.01 Cr 15.68 Cr 3.60 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -12.21 Cr
2024-09-30 0.00 Cr 0.00 Cr 0.00 Cr 2.09 Cr 0.00 Cr 5.51 Cr 0.01 Cr 15.65 Cr 3.43 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹395.80 ₹502,336,973,043.00 ₹3,554,697.00
Anthem Biosciences Ltd. ANTHEM ₹670.15 ₹376,432,537,248.00 ₹141,357.00
Piramal Pharma Limited PPLPHARMA ₹155.37 ₹205,611,590,763.00 ₹1,450,331.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,473.90 ₹168,940,186,680.00 ₹277,137.00
Syngene International Limited SYNGENE ₹409.30 ₹164,437,005,191.00 ₹675,182.00
Concord Biotech Limited CONCORDBIO ₹1,197.20 ₹125,246,519,429.00 ₹100,555.00
Jubilant Ingrevia Limited JUBLINGREA ₹570.75 ₹90,184,712,614.00 ₹363,355.00
Blue Jet Healthcare Limited BLUEJET ₹376.10 ₹65,240,346,343.00 ₹357,325.00
Supriya Lifescience Limited SUPRIYA ₹604.80 ₹48,675,997,440.00 ₹105,837.00
Zota Health Care Limited ZOTA ₹1,176.70 ₹35,692,435,139.00 ₹47,409.00
Dishman Carbogen Amcis Limited DCAL ₹164.51 ₹25,792,386,958.00 ₹431,232.00

Key Executives

Whole-Time Director & Chief Financial Officer
Konagalla Nagavenkata V. Narendra Kumar

Gender: male

Year Born: 1977

Company Secretary & Compliance Officer
Gita Usha Rani

Gender: female

Year Born:

Vice President of Operaiton
Srinagesh Adepu

Gender: Not Specified

Year Born: 1975

FAQs about Samsrita Labs Ltd.

Who is the CEO of the company?

The CEO is Konagalla Nagavenkata V. Narendra Kumar.

What is the current market price of the stock?

The current price is ₹17.67.

What is the 52-week price range?

The range is ₹12.19-26.04.

What is the market capitalization of the company?

The market capitalization is ₹26.17 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -5.12.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Samsrita Labs Ltd. (ISIN: INE579N01018) is a leading Biotechnology in India. With a market capitalization of ₹26.17 crores and an average daily volume of 1,429 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.